Method for the therapeutic management of extrauterine proliferatoin of endometrial tissue, chronic pelvic pain and fallopian tube obstruction

摘要

Disclosed is a use of an Luteinizing Hormone Releasing Hormone (LH-RH) antagonist as an active agent for the preparation of a medicament for the therapeutic management of extrauterine proliferation of endometrial tissue, or for the therapeutic management of chronic pelvic pain and/or fallopian tube obstruction (FTO) associated with the extrauterine proliferation of endometrial tissue, wherein the medicament is in a form providing an amount of LHRH antagonist for a treatment of about 4 to 12 weeks in the form of weekly doses of about 3 to 10 mg per week, daily doses of about 0.25 mg to 0.5 mg/day or monthly doses of about 12 to 40 mg per month. These LH-RH antagonist as an active agent are also suitable for use in combination with at least one active agent selected from the group consisting of a contraceptive, a non-steroidal anti-rheumatic agent, an analgetic, an androgen other than the 17-alpha alkyl substituted testosterone or any combinations thereof for the therapeutic management of extrauterine proliferation of endometrial tissue, or for the therapeutic management of chronic pelvic pain and/or fallopian tube obstruction (FTO) associated with the extrauterine proliferation of endometrial tissue.